Master switch to control aggressive breast cancers identified

Turns out, aggressive breast cancers return to a flexible, earlier state found in fetal breast tissue. This cellular reprogramming may be the key to cancer's ability to form new cell types, evolve drug resistance and metastasize to other locations in the body. A team of researchers at the Salk Institute has identified a master switch that appears to control the dynamic behavior of tumor cells that makes some aggressive cancers difficult to treat. The gene Sox10 directly control the growth and invasion of a significant fraction of hard-to-treat triple-negative breast cancers. To read the full article, click HERE

Eyes could be window to predicting Alzheimer's

Previous studies have found that the eyes of people who had died from Alzheimer's showed signs of thinning in the center of the retina and deterioration of the optic nerve. In this new study, Apte's team used a noninvasive technique called optical coherence tomography angiography to examine the thickness of the retinas and fibers in the optic nerves of 30 people, average age mid-70s, who had no symptoms of Alzheimer's. A form of the test is available at many eye doctors in the U.S. After the eye tests, PET scans and cerebrospinal fluid analyses revealed that about half of the study participants had elevated levels of the Alzheimer's-related proteins amyloid or tau. So, even though they didn'

Novartis trial win lifts profile of new breast cancer drug

Novartis’s efforts to tackle an elusive gene mutation behind tough-to-treat breast cancer were rewarded on Thursday, as the Swiss drugmaker said one of its investigational medicines slowed disease progression. nalysts said the drug, called BYL719, is on a trajectory to take a leading role in advanced breast cancer treatment. Novartis said its drug combined with hormone therapy improved progression-free survival in breast cancer patients whose tumors had hormone receptors but not so-called HER2 proteins. To read the full article, click HERE REUTERS/Arnd Wiegmann/File Photo

Borrowing from the cancer playbook to find treatment for Alzheimer's disease

It's been notoriously difficult to develop medicines for Alzheimer's disease, the sixth leading cause of death in the United States. Each year, it seems, pharmaceutical companies release data from studies of promising drug candidates that merit only a collective sigh of disappointment. In search of fresh ideas, researchers have begun to borrow a phrase or two from the more familiar language of cancer treatment. Some scientists are studying precision medicine, or personalized medicine, which is routinely used to treat breast and colon cancers. Other researchers are focusing on immunotherapy, an effective form of medicine for skin, lung, kidney, bladder and other cancers. This translation of t

New Treatments Offer Hope for Some Breast Cancer Patients

Recent studies show more women in the U.S. are living with metastatic breast cancer, or breast cancer that has spread. And many are living longer thanks in part to new treatments being tested to try to beat the disease. Morgan Mitchell and her fiance hit the gym five days a week. Morgan has four marathons under her belt, works at least 60 hours a week and travels for her job. She's doing all of this.. while battling stage 4 breast cancer. "Yeah I'm 29. And I had no family history to my knowledge," Mo/rgan says. "And then you got tested and you had the gene?" a reporter asks. "Yes I did have the gene." On the same day Bob proposed last November, Morgan discovered a lump in her br

Powerful sleeping pills boost the risk of Alzheimer’s, major study warns

Sleeping pills taken by hundreds of thousands may boost the risk of Alzheimer's, a study suggests. Researchers found the risk of developing the memory-robbing disorder is higher for patients taking benzodiazepines and Z-drugs. And the huge analysis revealed a higher risk for those on stronger medications, and for those who have taken the drugs for longer than recommended. Figures suggest there are at least 260,000 people in Britain and nearly 100 million in the US who take benzodiazepines and Z-drugs for at least a month. To read the full article, click HERE Photo Credit - Shutterstock - David Smart

What Women Should Know About Breast Cancer — No Matter Their Age

Breast cancer is scary, and for many women, it’s not something we really like to think about. However, as one of the most commonly diagnosed cancers in U.S. women (there are more than 3.1 million breast cancer survivors in the U.S. today), it’s important to be aware of the facts and understand that if ever faced with a diagnosis, you’re not going through it alone and you have options. Treatment and care for breast cancer have improved drastically over the years, so work with your doctor and talk to friends and family for support. Here are six important facts about breast cancer to keep in mind. To read the full article, click HERE Photo: Adobe stock

How Bill Gates Could Transform Alzheimer's Disease

America is finally making progress addressing our Alzheimer’s Problem. Particularly inspiring are discoveries of biomarker measures that allow physicians to accurately diagnose the disease early in its course. We’re also making progress in discovering treatments. Just last week, at the Alzheimer’s Association International Conference in Chicago, we learned that lowering blood pressure might reduce the risk of mild cognitive impairment, a condition that can worsen to dementia, and that Biogen’s antibody that targets brain amyloid might slow decline in persons with mild stage Alzheimer’s disease dementia. Truly, this progress isn’t surprising. Americans are a can-do, “put a man on the moon” pe

Scientists discover a dynamic cellular defense against breast cancer invasion

Johns Hopkins researchers report they have demonstrated in mouse tissue grown in the lab that the cell layer surrounding breast milk ducts reaches out to grab stray cancer cells to keep them from spreading through the body. The findings reveal that this cell layer, called the myoepithelium, is not a stationary barrier to cancer invasion, as scientists previously thought, but an active defense against breast cancer metastasis. Results of the scientists' experiments were published online this week in the Journal of Cell Biology. "Understanding how cancer cells are contained could eventually help us develop ways to predict a person's individualized risk of metastasis," says Andrew Ewald, a prof

Featured Posts
Recent Posts
Search By Tags
RSS Feed
  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

Connect with us on social media

© 2020 Care For A Cure, Inc. is a non-profit organization

with a 501(c)(3) tax exempt status. All rights reserved.